BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7421722)

  • 1. Use of dopamine and prazosin combined in the treatment of cardiogenic shock.
    Oliver LE; Horowitz JD; Dynon MK; Jarrott B; Brennan JB; Goble AJ; Louis WJ
    Med J Aust; 1980 Jul; 2(SP1):42-5. PubMed ID: 7421722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine for cardiogenic shock.
    Karliner JS
    JAMA; 1973 Dec; 226(10):1217-8. PubMed ID: 4800497
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of dopamine on cardiogenic and endotoxin experimental shock.
    Marchetti G; Longo T; Merlo L; Noseda V
    Eur Surg Res; 1973; 5(3):175-85. PubMed ID: 4584042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Our experience with the treatment of cardiogenic shock in recent myocardial infarction with dopamine and sodium nitroprusside].
    Korewicki J; Ostrzycki A; Opolski G
    Kardiol Pol; 1984; 27(5):345-51. PubMed ID: 6387246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D; Fleischmann HJ; Heunisch K; Köhler H; Trenckmann H
    Z Gesamte Inn Med; 1971 Dec; 26(24):759-63. PubMed ID: 5152441
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
    Lopez-Sendon J; Coma-Canella I; Lombera F; Jadraque LM
    Am Heart J; 1979 Oct; 98(4):495-504. PubMed ID: 484435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and therapeutic effects of intravenous dopamine.
    Théroux P; Mizgala HF; Bourassa MG
    Can Med Assoc J; 1977 Mar; 116(6):645-8. PubMed ID: 608165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive hemodynamic study of the acute oral administration of prazosin in stages I and II arterial hypertension].
    Agostini A; Antonini F; Pellegrini F; Rimatori C; Russo P
    Cardiologia; 1983 Jan; 28(1):55-60. PubMed ID: 6686938
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of combined dopamine and nitroprusside therapy in patients with severe pump failure and hypotension complicating acute myocardial infarction.
    Keung EC; Ribner HS; Schwartz W; Sonnenblick EH; LeJemtel TH
    J Cardiovasc Pharmacol; 1980; 2(2):113-9. PubMed ID: 6171679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of cardiogenic shock].
    Ritz R
    Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J; Karliner JS; O'Rourke RA; Pitt W; Ross J
    Am J Cardiol; 1973 Jul; 32(1):79-84. PubMed ID: 4713114
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopamine in the treatment of coronary shock].
    Zimin IuV; Kuznetsova GV; Evdokimov VV
    Kardiologiia; 1979 May; 19(5):34-9. PubMed ID: 459209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D; Esser H; Trübestein G
    Med Klin; 1977 Jul; 72(28-29):1212-7. PubMed ID: 329088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin versus propranolol plus prazosin: a comparison in diuretic-treated hypertensive patients.
    Kochar MS; Kalbfleisch JH; Blumenthal SS; Maierhofer WJ
    Am J Cardiol; 1984 Jan; 53(3):55A-58A. PubMed ID: 6695766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers.
    Elliott HL; McLean K; Sumner DJ; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1981 Mar; 29(3):303-9. PubMed ID: 6110503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D; Sebastien P; Bouvrain Y
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin: the first-dose phenomenon.
    Graham RM; Thornell IR; Gain JM; Bagnoli C; Oates HF; Stokes GS
    Br Med J; 1976 Nov; 2(6047):1293-4. PubMed ID: 793676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.